Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Aug 13, 2007

bioMérieux Contracts Sloning to Provide Gene Mutant Library for Use in Diagnostics Program

  • Sloning BioTechnology will carry out a feasibility study together with bioMérieux to generate a large number of gene variants of a particular enzyme that will be used in diagnostic applications.

    Sloning will use its Slonomics™ gene synthesis technology to provide a gene library with a full set of ratio-controlled mutants. The successful completion of the study will enable bioMérieux to identify an enzyme with significantly enhanced characteristics, according to the companies.

    “We are very excited about this collaboration. It gives Sloning the opportunity to demonstrate the capabilities of our enabling technology in the field of protein engineering and synthetic biology and in this particular case with a significant commercial impact to our customer,” states Heinz Schwer, Sloning’s CEO.



Be sure to take the GEN Poll

Drug Price Hikes

Novum Pharma recently raised the price of an acne cream by over 3,900% in less than a year-and-a-half and Mylan increased price of EpiPen from $100 to $608 . Do you think pharmaceutical companies need to be subjected to price controls?

More »